We are live on ! Find out more
MBE

Michael B. Elefante Portfolio holdings

AUM $91.5M Turnover 27.89%
1-Year Est. Return 13.24%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$240M
AUM Growth
+$8.34M
Cap. Flow
-$2.14M
Cap. Flow %
-0.89%
Top 10 Hldgs %
31.13%
Holding
156
New
16
Increased
22
Reduced
90
Closed
5
Avg Time Held
0.7 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.17M
2
ABT icon
Abbott
ABT
+$1.04M
3
TGT icon
Target
TGT
+$910K
4
XYL icon
Xylem
XYL
+$837K
5
XLNX
Xilinx Inc
XLNX
+$764K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$4.32M
2
ILMN icon
Illumina
ILMN
+$1.7M
3
PEP icon
PepsiCo
PEP
+$1.4M
4
NXPI icon
NXP Semiconductors
NXPI
+$668K
5
CVS icon
CVS Health
CVS
+$600K

Sector Composition

Rank Sector Weight
1 Technology 24.27%
2 Healthcare 21.64%
3 Industrials 17.46%
4 Energy 11.72%
5 Miscellaneous 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
NXPI icon
26
NXP Semiconductors
NXPI
$55.7B
$3.92M 1.64%
59,185
-10,900
-16% -$668K
2013 Q2
4 quarters
PRGO icon
27
Perrigo
PRGO
$2.21B
$3.81M 1.59%
26,143
+1,050
+4% +$149K
2013 Q2
4 quarters
IPGP icon
28
IPG Photonics
IPGP
$3.13B
$3.69M 1.54%
53,640
+5,050
+10% +$340K
2013 Q2
4 quarters
ABT icon
29
Abbott
ABT
$178B
$3.19M 1.33%
78,085
+26,590
+52% +$1.04M
2013 Q2
4 quarters
ILMN icon
30
Illumina
ILMN
$41B
$2.86M 1.19%
16,443
-11,375
-41% -$1.7M
2013 Q2
4 quarters
MSFT icon
31
Microsoft
MSFT
$3.96T
$2.64M 1.1%
63,416
– –
2013 Q2
4 quarters
CSCO icon
32
Cisco
CSCO
$448B
$2.53M 1.06%
101,913
+600
+0.6% +$14.3K
2013 Q2
4 quarters
HD icon
33
Home Depot
HD
$295B
$2.38M 1%
29,448
-150
-0.5% -$11.8K
2013 Q2
4 quarters
TGT icon
34
Target
TGT
$70.6B
$2.36M 0.98%
40,675
+15,475
+61% +$910K
2013 Q3
3 quarters
COV
35
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$2.31M 0.97%
25,673
-57,754
-69% -$4.32M
2013 Q2
4 quarters
LH icon
36
Labcorp
LH
$25.7B
$2.19M 0.91%
24,869
-3,341
-12% -$289K
2013 Q2
4 quarters
ABB
37
DELISTED
ABB Ltd
ABB
$2.13M 0.89%
92,675
– –
2013 Q2
4 quarters
XLNX
38
DELISTED
Xilinx Inc
XLNX
$1.61M 0.67%
34,025
+15,875
+87% +$764K
2013 Q4
2 quarters
SPY icon
39
State Street SPDR S&P 500 ETF Trust
SPY
$813B
$1.58M 0.66%
8,100
-1,525
-16% -$290K
2013 Q2
4 quarters
GIS icon
40
General Mills
GIS
$17.2B
$1.47M 0.61%
27,935
-100
-0.4% -$5.33K
2013 Q2
4 quarters
GE icon
41
GE Aerospace
GE
$319B
$1.28M 0.53%
10,134
-159
-2% -$20.2K
2013 Q2
4 quarters
GSK icon
42
GSK
GSK
$95.9B
$1.19M 0.5%
17,772
+9,852
+124% +$667K
2013 Q4
2 quarters
MRK icon
43
Merck
MRK
$364B
$1.15M 0.48%
20,871
-94
-0.4% -$5.13K
2013 Q2
4 quarters
HON icon
44
Honeywell
HON
$65.8B
$1.07M 0.45%
12,804
-495
-4% -$41.4K
2013 Q2
4 quarters
DD icon
45
DELISTED
Du Pont De Nemours E I
DD
$968K 0.4%
15,577
-527
-3% -$33.9K
2013 Q2
4 quarters
IBM icon
46
IBM
IBM
$215B
$911K 0.38%
5,257
-73
-1% -$13.1K
2013 Q2
4 quarters
XYL icon
47
Xylem
XYL
$24B
$875K 0.37%
+22,405
New +$837K
2014 Q2
0 quarters
ABBV icon
48
AbbVie
ABBV
$501B
$874K 0.36%
15,465
+515
+3% +$27K
2013 Q2
4 quarters
UNFI icon
49
United Natural Foods
UNFI
$2.88B
$868K 0.36%
13,327
+5,255
+65% +$351K
2013 Q2
4 quarters
GOOG icon
50
Alphabet (Google) Class C
GOOG
$4.2T
$758K 0.32%
+26,232
New +$712K
2014 Q2
0 quarters
1
2
3 4 5

Similar funds

AEPI
AH Equity Partners II Menlo Park, California $91.5M AUM
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
TM
TigerShark Management New York $98.9M AUM 11.4% 1-Year Est. Return
VNB
Valley National Bancorp New York $81.9M AUM 5.36% 1-Year Est. Return
ECP
Empirical Capital Partners Ringgold, Georgia $101M AUM
WIL
Winifred I. Li $106M AUM 11.93% 1-Year Est. Return
RCM
Raptor Capital Management Boston, Massachusetts $73.2M AUM 23.77% 1-Year Est. Return
ZTNA
Zions Trust National Association Salt Lake City, Utah $69.4M AUM 2.73% 1-Year Est. Return

Michael B. Elefante's Q2 2014 Portfolio in Review

As of Q2 2014, Michael B. Elefante held 156 positions worth $240M, up 3.6% from $231M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael B. Elefante's Q2 2014 filing shows 16 new, 22 increased, 90 reduced and 5 closed positions. Its largest new stake was Xylem: 22,405 shares worth $875K. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $4.32M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Michael B. Elefante's largest Q2 2014 buy was Xylem: 22,405 shares worth $875K.
  • Michael B. Elefante added most to Qualcomm in Q2 2014, an estimated $1.17M increase.
  • Michael B. Elefante's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $4.32M.
  • Michael B. Elefante fully exited Aflac in Q2 2014, selling an estimated $91K.
  • Michael B. Elefante's ten largest holdings make up 31% of its $240M portfolio in Q2 2014.
  • Michael B. Elefante opened 16 new positions and closed 5 in Q2 2014.
  • Michael B. Elefante's portfolio value rose 3.6% quarter-over-quarter to $240M.

Based on Michael B. Elefante's 13F filing for Q2 2014, filed 24 Jul 2014.